KLK3 and Familial prostate cancer: ProtecT is the largest randomised controlled trial to date comparing the effectiveness and cost-effectiveness of active monitoring, radical prostatectomy or external beam 3D conformal radiotherapy with neo-adjuvant androgen deprivation for men with clinically localised prostate cancer detected following PSA testing and transrectal ultrasound guided biopsies [3].